Skip to content

MRI and neuropsychological evaluation in systemic sclerosis

MRI and neuropsychological evaluation in systemic sclerosis - MRI and neuropsychological evaluation in systemic sclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39408
Enrollment
200
Registered
2012-04-10
Start date
2012-10-19
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scleroderma systemic sclerosis

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. systemic sclerosis according to ACR criteria 2. presence of cognitive dysfunction, fatigue, concentration loss, and/or depression

Exclusion criteria

Exclusion criteria: 1. Routine MRI-contraindications (e.g. instable metal implants, pacemaker/ICD, vascular clips, fear). 2. Pregnancy

Design outcomes

Primary

MeasureTime frame
The following questionnaires: Fatigue Indez (MVI-20) the Hospital Anxiety and Depression Scale (HADS) the Dissociation Experience Scale (DES), and the Neuropsychiatric Inventory (NPI). The following functional neuropsychology tests are performed at the department of Neurology: a) global functioning (assessed by Mini mental state examination (MMSE), b) memory (Wechsler Memory scale), c) executive testing (Trails, Stroop, Wais-R substitution, number strike through test, d) language: (Word Fluency, naming pictures, writing and calculating) e) praxis (drawing a clock, map and cube). The following neuroimaging parameters: 1)Diffusion Weighted Imaging (DWI) 2)Single Voxel Proton Magnetic Resonance Spectroscopy (H1-MRS)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)